Mark A Socinski

8PUBLICATIONS
78CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 05, 2025
Phase 2 Study of Zilovertamab Vedotin in Participants with Metastatic Solid Tumors.

Funda Meric-Bernstam, Martin Gutierrez, Enrique Sanz-Garcia

|Sep 13, 2023
Circulating Tumor DNA Monitoring on Chemo-immunotherapy for Risk Stratification in Advanced Non-Small Cell Lung Cancer.

Bruna Pellini, Russell W Madison, Merrida A Childress

|Jun 29, 2023
Safety, Tolerability, and Antitumor Activity of Zipalertinib Among Patients With Non-Small-Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Exon 20 Insertions.

Zofia Piotrowska, Daniel Shao-Weng Tan, Egbert F Smit

|Jan 03, 2023
Tumor Dynamic Model-Based Decision Support for Phase Ib/II Combination Studies: A Retrospective Assessment Based on Resampling of the Phase III Study IMpower150.

René Bruno, Mathilde Marchand, Kenta Yoshida

Pageof 2